Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 1996;27:1578-1585

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Coimbra, C.
Right arrow Articles by Corbett, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Coimbra, C.
Right arrow Articles by Corbett, D.

(Stroke. 1996;27:1578-1585.)
© 1996 American Heart Association, Inc.


Articles

Long-lasting Neuroprotective Effect of Postischemic Hypothermia and Treatment With an Anti-inflammatory/Antipyretic Drug

Evidence for Chronic Encephalopathic Processes Following Ischemia

Cicero Coimbra, MD, PhD; Mikael Drake, MD; Fredrik Boris-Moller, MD Tadeusz Wieloch, MD, PhD

the Laboratory for Experimental Brain Research, Lund (Sweden) University, and Laboratory for Experimental Neurology, Escola Paulista de Medicina, Sao Paulo, Brazil (C.C.)

Correspondence to Dr Cicero Coimbra, Laboratory for Experimental Neurology, Escola Paulista de Medicina, R Botucatu 862, 04023-900, Sao Paulo, Brazil.

Background and Purpose It has been recognized that postischemic pharmacological interventions may delay the evolution of neuronal damage rather than provide long-lasting neuroprotection. Also, fever complicates recovery after stroke in humans. Here we report the effects of late postischemic treatment with hypothermia and an antipyretic/anti-inflammatory drug, dipyrone, on cell damage at 1 week and 2 months of survival.

Methods Rats were subjected to 10 minutes of forebrain ischemia. Hypothermia (33°C) was induced at 2 hours of recovery and maintained for 7 hours. Dipyrone (100 mg·kg-1IP) was given every 3 hours from 14 to 72 hours of recovery. Temperature was measured every 6 hours for 60 days. Neuronal damage was assessed at 7 days and 2 months of recovery.

Results From 17 to 72 hours of recovery, a period of hyperthermia was observed, which dipyrone abolished but postischemic hypothermia treatment did not. Dipyrone treatment diminished neuronal damage by 43% at 7 days, and at 2 months of survival, a minor (16%) protection was seen. Postischemic hypothermia treatment alone delayed neuronal damage. In contrast, combined treatment of hypothermia followed by dipyrone markedly diminished neuronal damage by more than 50% at both 7 days and 2 months of recovery.

Conclusions Neuronal degeneration may be ongoing for months after a transient ischemic insult, and prolonged protective measures need to be instituted for long-lasting neuroprotective effects. Hyperthermia during recovery worsens ischemic damage, and processes associated with inflammation may contribute to the development of neuronal damage. An early and extended period of postischemic hypothermia provides a powerful and long-lasting protection if followed by treatment with anti-inflammatory/antipyretic drugs.

Editorial Comment

Evidence for Chronic Encephalopathic Processes Following Ischemia

Dale Corbett, PhD, Guest Editor

Division of Basic Medical SciencesFaculty of MedicineMemorial University of NewfoundlandSt John's, NF, Canada




This article has been cited by other articles:


Home page
J. Neurosci.Home page
X. Wang, S. Zhu, Z. Pei, M. Drozda, I. G. Stavrovskaya, S. J. Del Signore, K. Cormier, E. M. Shimony, H. Wang, R. J. Ferrante, et al.
Inhibitors of Cytochrome c Release with Therapeutic Potential for Huntington's Disease
J. Neurosci., September 17, 2008; 28(38): 9473 - 9485.
[Abstract] [Full Text] [PDF]


Home page
Therapeutic Advances in Neurological DisordersHome page
B. P. Meloni, F. L. Mastaglia, and N. W. Knuckey
Review: Therapeutic applications of hypothermia in cerebral ischaemia
Therapeutic Advances in Neurological Disorders, September 1, 2008; 1(2): 75 - 98.
[Abstract] [PDF]


Home page
StrokeHome page
S. J. Spencer, A. Mouihate, and Q. J. Pittman
Peripheral Inflammation Exacerbates Damage After Global Ischemia Independently of Temperature and Acute Brain Inflammation
Stroke, May 1, 2007; 38(5): 1570 - 1577.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
The International Liaison Committee on Resuscitati
The International Liaison Committee on Resuscitation (ILCOR) Consensus on Science With Treatment Recommendations for Pediatric and Neonatal Patients: Pediatric Basic and Advanced Life Support
Pediatrics, May 1, 2006; 117(5): e955 - e977.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
Part 4: Advanced Life Support
Circulation, November 29, 2005; 112(22_suppl): III-25 - III-54.
[Full Text] [PDF]


Home page
CirculationHome page
Part 6: Pediatric Basic and Advanced Life Support
Circulation, November 29, 2005; 112(22_suppl): III-73 - III-90.
[Full Text] [PDF]


Home page
StrokeHome page
H. J. Audebert, M. M. Rott, T. Eck, and R. L. Haberl
Systemic Inflammatory Response Depends on Initial Stroke Severity but Is Attenuated by Successful Thrombolysis
Stroke, September 1, 2004; 35(9): 2128 - 2133.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
D. J. Gladstone, S. E. Black, and A. M. Hakim
Toward Wisdom From Failure: Lessons From Neuroprotective Stroke Trials and New Therapeutic Directions
Stroke, August 1, 2002; 33(8): 2123 - 2136.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
L. B. Becker, M. L. Weisfeldt, M. H. Weil, T. Budinger, J. Carrico, K. Kern, G. Nichol, I. Shechter, R. Traystman, C. Webb, et al.
The PULSE Initiative: Scientific Priorities and Strategic Planning for Resuscitation Research and Life Saving Therapies
Circulation, May 28, 2002; 105(21): 2562 - 2570.
[Full Text] [PDF]


Home page
StrokeHome page
R. L. Roof, G. P. Schielke, X. Ren, and E. D. Hall
A Comparison of Long-Term Functional Outcome After 2 Middle Cerebral Artery Occlusion Models in Rats
Stroke, November 1, 2001; 32(11): 2648 - 2657.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
A. Doerfler, S. Schwab, T. T. Hoffmann, T. Engelhorn, and M. Forsting
Combination of Decompressive Craniectomy and Mild Hypothermia Ameliorates Infarction Volume After Permanent Focal Ischemia in Rats
Stroke, November 1, 2001; 32(11): 2675 - 2681.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
G. B. Mackensen, M. Patel, H. Sheng, C. L. Calvi, I. Batinic-Haberle, B. J. Day, L. P. Liang, I. Fridovich, J. D. Crapo, R. D. Pearlstein, et al.
Neuroprotection from Delayed Postischemic Administration of a Metalloporphyrin Catalytic Antioxidant
J. Neurosci., July 1, 2001; 21(13): 4582 - 4592.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
H. Dong, F. Moody-Corbett, F. Colbourne, Q. Pittman, and D. Corbett
Electrophysiological Properties of CA1 Neurons Protected by Postischemic Hypothermia in Gerbils
Stroke, March 1, 2001; 32(3): 788 - 795.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
A. J. Gunn and P. D. Gluckman
Should We Try to Prevent Hyperthermia After Cardiac Arrest?
Pediatrics, July 1, 2000; 106(1): 132 - 133.
[Full Text]


Home page
StrokeHome page
H. Yanamoto, I. Nagata, I. Nakahara, N. Tohnai, Z. Zhang, H. Kikuchi, and C. Iadecola
Combination of Intraischemic and Postischemic Hypothermia Provides Potent and Persistent Neuroprotection Against Temporary Focal Ischemia in Rats • Editorial Comment
Stroke, December 1, 1999; 30(12): 2720 - 2726.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
R. Schmid-Elsaesser, E. Hungerhuber, S. Zausinger, A. Baethmann, H.-J. Reulen, and J. A. Zivin
Combination Drug Therapy and Mild Hypothermia : A Promising Treatment Strategy for Reversible, Focal Cerebral Ischemia • Editorial Comment: A Promising Treatment Strategy for Reversible, Focal Cerebral Ischemia
Stroke, September 1, 1999; 30 (9): e1891 - 1899.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
G. P. Schielke, N. C. Kupina, P. A. Boxer, C. F. Bigge, D. F. Welty, and C. Iadecola
The Neuroprotective Effect of the Novel AMPA Receptor Antagonist PD152247 (PNQX) in Temporary Focal Ischemia in the Rat • Editorial Comment
Stroke, July 1, 1999; 30(7): 1472 - 1477.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
H. Sheng, D. T. Laskowitz, G. B. Mackensen, M. Kudo, R. D. Pearlstein, D. S. Warner, and C. Iadecola
Apolipoprotein E Deficiency Worsens Outcome From Global Cerebral Ischemia in the Mouse • Editorial Comment
Stroke, May 1, 1999; 30(5): 1118 - 1124.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
A. J. Gunn, T. R. Gunn, M. I. Gunning, C. E. Williams, and P. D. Gluckman
Neuroprotection With Prolonged Head Cooling Started Before Postischemic Seizures in Fetal Sheep
Pediatrics, November 1, 1998; 102(5): 1098 - 1106.
[Abstract] [Full Text]


Home page
StrokeHome page
F. Colbourne, R. N. Auer, G. R. Sutherland, and W. D. Dietrich
Behavioral Testing Does Not Exacerbate Ischemic CA1 Damage in Gerbils • Editorial Comment
Stroke, September 1, 1998; 29(9): 1967 - 1971.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
M. D. Ginsberg and R. Busto
Combating Hyperthermia in Acute Stroke : A Significant Clinical Concern
Stroke, February 1, 1998; 29(2): 529 - 534.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
D. Corbett, S. Nurse, and F. Colbourne
Hypothermic Neuroprotection : A Global Ischemia Study Using 18- to 20-Month-Old Gerbils
Stroke, November 1, 1997; 28(11): 2238 - 2243.
[Abstract] [Full Text]